Strengthening Physician Communication About HPV Vaccines

University of Colorado, Denver1 site in 1 country93,582 target enrollmentFebruary 1, 2015

ConditionsHPV Immunization Status

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: HPV Immunization Status
Sponsor: University of Colorado, Denver
Enrollment: 93582
Locations: 1
Primary Endpoint: The percentage of adolescents who initiate the HPV vaccine series
Status: Completed
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to determine if a multimodal Human Papillomavirus (HPV) immunization program carried out in pediatric and family medicine practices would be more effective in improving adolescent patients' HPV immunization rates than the usual care provided to adolescents in pediatric and family medicine practices.

Registry

clinicaltrials.gov

Start Date

February 1, 2015

End Date

January 31, 2016

Last Updated

6 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

University of Colorado, Denver

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Less than 9 years of age when presenting for care
•Patient is not eligible for HPV immunization
•Provider survey:
•Providers who are working at participating practices during the two times a cross-sectional survey is administered.
•Parent survey:
•Parents of adolescents who presented for care within one 1 year prior to the two times a cross-sectional survey is administration.

Outcomes

Primary Outcomes

The percentage of adolescents who initiate the HPV vaccine series

Time Frame: 1 year

The percent of eligible patients presenting for care at intervention offices who receive one or more HPV vaccines (using administrative, Electronic Medical Records (EMR), and Colorado Immunization Information System (CIIS) immunization data), during the intervention year, compared to the percent in control offices.

Secondary Outcomes

Provider HPV vaccine recommendations(1 year)
Parents' experiences and preferences regarding provider communication about HPV vaccines(1 year)
The percentage of adolescents who receive MCV4 vaccine(1 year)
The percentage of adolescents who receive Tdap vaccine(1 year)